)
PharmaCorp Rx (PCRX) investor relations material
PharmaCorp Rx Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Operates as a Canadian pharmacy consolidator with four pharmacies under the PharmaChoice Canada banner as of December 2025, expanding with three new pharmacy acquisitions post-quarter-end.
Holds exclusive right-of-first-refusal to acquire 1,100+ pharmacies, supporting an acquisition-led growth strategy.
Secured a new credit facility with CIBC and raised $23.0M through a public offering in November 2025.
Signed a letter of intent for a new acquisition in Western Canada for $350,000 in December 2025.
Led by an experienced executive and governance team with deep industry expertise.
Financial highlights
Q3 2025 Adjusted EBITDA (Pre-IFRS 16, 4-Wall basis) reached $840.6K, up from $707.4K in Q1 and $688.0K in Q2.
Same store script count grew 7.2% year-over-year in Q3, with same store sales up 9.4%.
Net loss for the quarter was impacted by infrastructure investments, stock option grants, and one-time legal fees related to a new credit facility.
Balance sheet as of September 30, 2025: $5.0M cash, $39.7M total assets, $9.5M total liabilities, $30.2M total equity.
Subsequent $23M capital raise further strengthened the balance sheet.
Outlook and guidance
Acquisition pipeline remains strong, with 40+ new stores joining the PCC banner annually and 40-50 stores turning over each year.
Targeted adjusted EBITDA lift of 7.5-15% over three years post-acquisition through operational improvements.
Management remains focused on disciplined, accretive growth through acquisitions and maintaining a disciplined weighted average EBITDA multiple.
Positioned to scale nationally, leveraging exclusive acquisition rights and new financing.
Ongoing interest from independent pharmacy owners supports future acquisition opportunities.
Next PharmaCorp Rx earnings date
Next PharmaCorp Rx earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)